https://www.has-sante.fr/jcms/p_3644626/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacaftor-en-association-avec-kalydeco-mucoviscidose-2-ans-et-plus 2025 France evaluation of the transparency committee tezacaftor, ivacaftor drug combination elexacaftor ivacaftor elexacaftor cystic fibrosis ivacaftor cystic fibrosis tezacaftor association kalydeco
--- https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose 2024 false false false France infant child evaluation of the transparency committee ivacaftor cystic fibrosis ivacaftor Ivacaftor Cystic Fibrosis cystic fibrosis kalydeco ivacaftor
--- https://www.has-sante.fr/jcms/p_3343182/fr/kalydeco-ivacaftor-mucoviscidose-6-ans 2022 false false false France evaluation of the transparency committee cystic fibrosis Cystic fibrosis ivacaftor cystic fibrosis traction indication of kalydeco ivacaftor ivacaftor indicators indicators and reagents